PATTERN PHARMA

pattern-pharma-logo

Pattern Pharma is a life sciences company that develops novel therapeutics that use the innate immune system to fight cancer and infectious disease. P2PAR, Pattern's lead product, is an immunotherapeutic that uses innate immune cells to kill cancer cells while also safely activating an efficacious innate and adaptive immune response, overcoming many of the limitations of traditional therapies.

#SimilarOrganizations #People #Website #More

PATTERN PHARMA

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Address:
Toronto, Ontario, Canada

Country:
Canada

Website Url:
http://www.patternpharma.com

Total Employee:
1+

Status:
Active

Contact:
416-302-5155

Email Addresses:
[email protected]

Technology used in webpage:
SPF Google Apps For Business GoDaddy DNS CPanel SSL OVH


Similar Organizations

groove-biopharma-logo

Groove Biopharma

Groove Biopharma develops novel microRNA therapeutics for maladies including cancer, fibrosis and infectious diseases.

merck-logo

Merck

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

osprey-pharmaceuticals-usa-logo

Osprey Pharmaceuticals USA

Osprey Pharmaceuticals USA develops novel protein therapeutics for the treatment of inflammatory and immune diseases.

not_available_image

Tollbridge Theapeutics Inc.

Tollbridge Theapeutics develops innovative therapies that use the immune system to fight cancer and other diseases.

Current Employees Featured

not_available_image

Andrew Williams
Andrew Williams Chief Financial Officer @ Pattern Pharma
Chief Financial Officer
2020-12-01

Founder


mark-f-de-groot_image

Mark F de Groot

Official Site Inspections

http://www.patternpharma.com

  • Host name: 198.50.215.64
  • IP address: 198.50.215.64
  • Location: Montreal Canada
  • Latitude: 45.5063
  • Longitude: -73.5794
  • Timezone: America/Toronto
  • Postal: H3A

Loading ...

More informations about "Pattern Pharma"

Team - Pattern Pharma

In this role, Dee was responsible for leading the companyโ€™s transition from a research and development organization to a successful commercial enterprise. Before joining SDPO, she โ€ฆSee details»

Pattern Pharma - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 416-302-5155 Pattern Pharma is a life sciences company that develops novel therapeutics that use the innate immune system to โ€ฆSee details»

Pattern Pharma Company Profile | Management and Employees โ€ฆ

[email protected]: Pattern Pharma Top Competitors. Company Employees Revenue Top technologies; Medesis Pharma. 14: $4.7 M: Biomolecules for Life Inc. 9: $3.8 M: โ€ฆSee details»

Pattern Pharma Company Profile 2024: Valuation, Funding

Pattern Pharma General Information Description. Developer of a novel therapeutics designed to combat cancer and infectious disease. The company's therapeutics is a significantly improved, โ€ฆSee details»

Pattern Pharma - LinkedIn

Pattern Pharma | 274 followers on LinkedIn. Making patients innately better | Patternโ€™s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity to address the immune โ€ฆSee details»

Pattern Pharma | Ontario at BIO 2023 | Source from Ontario

May 31, 2023 patternpharma.com Contact. Mark de Groot, CEO . Tel: +1 416-302-5155. Email: [email protected]. Event details. Name: Ontario at BIO 2023. Date: June 5 - 8, โ€ฆSee details»

Pattern Pharma - Products, Competitors, Financials, Employees ...

Patternpharma.com. Overview & Products; Financials; People; Founded Year 2018. Stage Unattributed - V | Alive. Total Raised $7.86M. Last Raised $3.92M | 3 yrs ago. About Pattern โ€ฆSee details»

Pattern Pharma Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Pattern Pharma Inc. of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»

Pattern Pharma - Overview, News & Similar companies - ZoomInfo

Who is Pattern Pharma. Pattern Pharma is a North American immunotherapy company whose P2PAR product systemically activates the innate immune system (dendritic cells, macr โ€ฆSee details»

Pattern Pharma Inc. - VentureRadar

"Pattern Pharma is dedicated to revolutionizing cancer treatment through the development of PPI-100, a novel immunotherapy designed for perioperative use.See details»

Pattern Pharma Inc. · 199 Bay Street, Suite 4000, Toronto, ON M5L โ€ฆ

Pattern Pharma Inc. is a federal corporation in Toronto, Ontario incorporated with Corporations Canada, a division of Innovation, Science and Economic Development (ISED) Canada. The โ€ฆSee details»

Pattern Pharma Inc. | Canada Corporation Directory

Pattern Pharma Inc. is a Non-distributing corporation with 50 or fewer shareholders corporation type, which located at 199 Bay Street, Suite 4000 Toronto ON M5L 1A9 Canada.See details»

Pattern Pharma Inc. | Source From Ontario

Pattern Pharmaโ€™s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting TLR4, in order to address cancers and infectious diseases. PPI-100 activates innate โ€ฆSee details»

Pattern Pharma Inc. | Source From Ontario

Www.patternpharma.com Contact . Mark de Groot, Directeur général . Tél : +1 416-302-5155. Courriel : [email protected]. Renseignements sur l'événement. Nom: L'Ontario à โ€ฆSee details»

Mark F. de Groot - Pattern Pharma | LinkedIn

Mark has 25+ years of life-sciences experience in operations, investment and finance, with a long-standing interest in utilizing the immune system (our most powerful tool for maintaining well โ€ฆSee details»

Ontario at BIOTECH Showcase 2024 - Source From Ontario

Patternpharma.com Contact. Mark de Groot, CEO . Tel: +1 416-302-5155. Email: [email protected]. Event details. Name: Ontario at BIOTECH Showcase 2024. โ€ฆSee details»

Immunotherapy company Pattern Pharma grabs financing

Sep 29, 2021 Pattern Pharma, a Toronto-based immunotherapy company focused on combating cancer and infectious disease, has collected C$5 million in financing.See details»

Pattern Pharma | Source From Ontario

Pattern Pharmaโ€™s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting TLR4, in order to address the immune failure underpinning cancers. PPI-100 โ€ฆSee details»

Mark deGroot - CEO & Co-Founder @ Realist Pharma - Crunchbase

Mark de Groot, Ph.D. co-founded Virage Capital and serves as its Managing Director. Mark de Groot has extensive experience, domestically and internationally, in architecting both new โ€ฆSee details»

linkstock.net © 2022. All rights reserved